Schear Investment Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,412
Closed -$608K 80
2025
Q4
$608K Sell
7,412
-7,227
-49% -$563K 0.26% 67
2025
Q3
$1.1M Sell
14,639
-269
-2% -$20.1K 0.49% 60
2025
Q2
$1.1M Sell
14,908
-145
-1% -$10.1K 0.55% 59
2025
Q1
$1.21M Buy
15,053
+135
+0.9% +$11.6K 0.7% 52
2024
Q4
$1.17M Sell
14,918
-968
-6% -$82.3K 0.62% 48
2024
Q3
$1.49M Buy
15,886
+318
+2% +$26.7K 0.92% 37
2024
Q2
$1.21M Buy
15,568
+3,835
+33% +$313K 0.88% 39
2024
Q1
$1.07M Buy
+11,733
New +$976K 0.86% 40

Other funds holding GEHC

Schear Investment Advisers's GEHC Position: Q1 2026 in Review

Schear Investment Advisers sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 7,412 shares — an estimated $608K sold.

Schear Investment Advisers first reported a position in GEHC in Q1 2024 and held it in 8 quarters. The position peaked at $1.49M in Q3 2024. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Schear Investment Advisers reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Schear Investment Advisers sold 7,412 GE HealthCare shares in Q1 2026, an estimated $608K.
  • Schear Investment Advisers first reported a position in GE HealthCare in Q1 2024 and held it in 8 quarters.
  • Schear Investment Advisers's GE HealthCare position peaked at $1.49M in Q3 2024.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Schear Investment Advisers's 13F filing for Q1 2026, filed 28 Apr 2026.